Asimov has launched the LV Edge Packaging System, which reduces the cost and supply chain risk of lentiviral production. The system integrates viral genes into the host cell, allowing lentiviral production from a single-plasmid transfection, as opposed to the standard four-plasmid process. This reduces manufacturing costs and supply chain risk without compromising speed to market. The system achieves high harvest titers and enables tuneable transgene expression in the transduced cell. Asimov plans to expand the offering with a fully-stable lentiviral producer cell line development service later this year. This system deepens their commitment to genetic design capabilities. For more information, visit www.asimov.com/LV.
Source link
Asimov launches LV Edge Packaging System to optimize lentivirus production
